August 31, 2018

Is Your Blood Pressure Medicine Being Recalled?

The Latest from Health Central. Forward to a friend | View Online
 
t.png p.png
8975842d-d31a-4ad4-95a9-bcce47223048.jpg
Common Blood Pressure Meds Recalled
FDA — Some generic versions of a common medication used to treat high blood pressure and heart failure, valsartan, contain an impurity that doesn't meet safety standards. Here's what you need to know.
Read More »
Stroke Doubles Dementia Risk, Large Study Finds
Alzheimer's & Dementia — Even after adjusting for other dementia risk factors like high blood pressure, diabetes, and heart disease, stroke victims are about twice as likely to develop dementia, according to study involving 3.2 million people.
Read More »
Surprised by That Medical Bill? You Aren't Alone
NORC at the University of Chicago — More than half of Americans surveyed, 57 percent, report that they've been surprised by an unexpected medical bill they believed would be covered by their health insurance.
Read More »
What Works for Fibromyalgia Pain?
Berkeley Wellness — Widespread, chronic pain caused by fibromyalgia often requires a flexible treatment approach. Here are some strategies to improve your quality of life with fibromyalgia.
Read More »
What You Should Know About Osteoporosis
HealthCentral — Did you know that a bone fracture caused by falling from a standing position or lower is a sign of osteoporosis? Here, we dispel common misconceptions about thinning bones.
Read More »
imp?s=187247&sz=300x250&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23
imp?s=187248&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=187249&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23
imp?s=95371&sz=116x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=96074&sz=69x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23
What you missed this week
More from Heath Central
The Remedy Health Network
Berkeley Wellness science-backed, expert-vetted health and wellness advice

The Body current and complete coverage for the HIV/AIDS community
Newsletter Options
This email was sent to clrmyers6@gmail.com

We're happy to help you unsubscribe or manage your email preferences.

If this email was forwarded to you by another email recipient and you would like to subscribe, click here.

Ensure you receive this newsletter by adding us to your safe sender's list.

You can also forward this newsletter to a friend.
t.png p.png
imp?s=124359000&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359001&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359002&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359003&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359004&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359005&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359006&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359007&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359008&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359009&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359010&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359011&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359012&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359013&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359014&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359015&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359016&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359017&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359018&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23 imp?s=124359019&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=3809a2db23

August 30, 2018

Drug for Progressive MS Shows Promise in Clinical Trials

The Latest from Health Central. Forward to a friend | View Online
 
t.png p.png
8975842d-d31a-4ad4-95a9-bcce47223048.jpg
Drug for Progressive MS Shows Promise in Clinical Trials
Health Central — Cleveland Clinic researchers led phase 2 clinical trials for an oral medication, ibudilast, that slowed brain shrinkage in people with progressive multiple sclerosis by 48 percent.
Read More »
STD Rates Hit New Highs for the Fourth Straight Year
CDC — Preliminary information from the CDC suggests nearly 2.3 million cases of chlamydia, gonorrhea, and syphilis were diagnosed in the U.S. in 2017.
Read More »
Many U.S. Soldiers Who Attempt Suicide Have No Mental Illness History
JAMA Psychiatry — Among the 9,650 soldiers in the U.S. Army with a documented suicide attempt, more than a third had no previous mental health diagnosis, according to new data.
Read More »
Antidepressants and Sexual Problems
Berkeley Wellness — People who take antidepressants often experience sex­ual problems, including erectile dysfunction, which can begin immediately or several months after starting treatment for depression.
Read More »
7 Things You Don't Know About Diabetes Unless You Have It
HealthCentral — If living with diabetes were as simple as it's portrayed, the cure would involve an insulin pump, a diet of oatmeal and chicken rather than ice cream and doughnuts, and weight loss. Wrong.
Read More »
imp?s=187247&sz=300x250&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb
imp?s=187248&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=187249&sz=1x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb
imp?s=95371&sz=116x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=96074&sz=69x15&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb
More from Health Central
The Remedy Health Network
Berkeley Wellness science-backed, expert-vetted health and wellness advice

The Body current and complete coverage for the HIV/AIDS community
Newsletter Options
This email was sent to clrmyers6@gmail.com

We're happy to help you unsubscribe or manage your email preferences.

If this email was forwarded to you by another email recipient and you would like to subscribe, click here.

Ensure you receive this newsletter by adding us to your safe sender's list.

You can also forward this newsletter to a friend.
t.png p.png
imp?s=124359000&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359001&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359002&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359003&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359004&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359005&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359006&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359007&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359008&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359009&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359010&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359011&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359012&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359013&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359014&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359015&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359016&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359017&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359018&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb imp?s=124359019&sz=2x1&li=%7BLIST_ID%7D&e=clrmyers6@gmail.com&p=dff5717cbb